[1]颜秀娟,邱昌文,石庆秋,等.核酸检测技术在血液筛查中的应用评估及建议[J].中国卫生质量管理,2011,18(02):036.
 YAN Xiujuan,QIU Changwen,SHI Qingqiu,et al.Application Assessment and Recommendations of Nucleic Acid Testing in Blood Screening[J].Chinese Health Quality Management,2011,18(02):036.
点击复制

核酸检测技术在血液筛查中的应用评估及建议
分享到:

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第18卷
期数:
2011年02期
页码:
036
栏目:
栏目一
出版日期:
2011-04-30

文章信息/Info

Title:
Application Assessment and Recommendations of Nucleic Acid Testing in Blood Screening
作者:
颜秀娟; 邱昌文; 石庆秋; 谢家日; 罗必泰;
南宁中心血站检验科;
Author(s):
YAN XiujuanQIU ChangwenSHI Qingqiuet al
Department of Clinical Laboratory,Blood Center of Nanning City,Nanning,Guangxi,530003,China
关键词:
核酸检测 血液筛查 应用评估 建议
Keywords:
Nucleic Acid Testing Blood Screening Application Assessment Recommendations
分类号:
R446.6
摘要:
通过对现行血清学检测模式及检测试剂劣势的分析,指出NAT血液筛查可有效降低经输血传播疾病的风险。并结合工作实践,就NAT血液筛查在我国的应用与推广提出了相关建议。 更多还原
Abstract:
Through the analysis of existing serological detection models and quality of test reagents,the study pointed out that Nucleic Acid Testing(NAT) blood screening can effectively reduce the risk of diseases transmission by blood transfusion.Combined with the practice,the paper discussed issues needing to be paied attention to and related recommendations in NAT blood screening.

相似文献/References:

[1]杨转笑 肖慧芬 肖忠 邬旭群 方瑛 黄华霖.深圳地区HBV核酸检测反应性献血者两种归队模式风险评估研究[J].中国卫生质量管理,2020,27(03):111.
 YANG Zhuanxiao,XIAO Huifen,XIAO Zhong,et al.Risk Assessment of Two Regrouped Modes of Reactive Blood Donors with HBV Nucleic Acid Detection in Shenzhen Area[J].Chinese Health Quality Management,2020,27(02):111.
[2]崔有文董静怡姚京京冯熙龙.医疗机构重点人群核酸检测监管平台构建与应用[J].中国卫生质量管理,2023,30(03):068.[doi:10.13912/j.cnki.chqm.2023.30.3.14 ]
 CUI Youwen,DONG Jingyi,YAO Jingjing.Construction and Application of Nucleic Acid Detection Monitoring Platform for Key Population in Medical Institutions[J].Chinese Health Quality Management,2023,30(02):068.[doi:10.13912/j.cnki.chqm.2023.30.3.14 ]

更新日期/Last Update: 2011-04-30